全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Prevalence of Abnormal Cervical Cytology among Postnatal Clinic Attendees at the University of Calabar Teaching Hospital, Nigeria

DOI: 10.4236/oalib.1102992, PP. 1-14

Subject Areas: Gynecology & Obstetrics

Keywords: Cervical Cancer, Prevention, Pap Smear, Postpartum Women, UCTH

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Carcinoma of the uterine cervix is a deadly disease, but it is preventable. Cervical cytology especially at postnatal visit can lead to its early detection and prompt treatment. Methods: This was a prospective cross sectional study of postnatal women to determine the prevalence of abnormal cervical cytology and their socio-demographic characteristics. Patients were recruited from the antenatal clinic and counseled on the need for postnatal cervical smear. Only those who consented and met the inclusion criteria were followed up in the postnatal clinic. Institutional ethical clearance was also obtained. Researcher administered questionnaire was used to collect the socio-demographic features while Aye’s spatula and endocervical brush were used to collect specimen from the ectocervix and endocervix respectively and smeared on individually labeled glass slides. The samples were treated using the conventional Papanicolaou staining method and reported using the Bethesda system. Researcher-administered questionnaire generated data as well as results of cytology were analyzed using Epi-Info version 3.5.1.0 (CDC Atlanta USA 2008). Colposcopy was done for smear positive patients. Results: There were 100 women screened. Three percent had low grade squamous intraepithelial lesion. There were no abnormal findings from the Colposcopy of the three patients. Ninety-five percent of the women had no prior knowledge of cervical cancer and Pap smear. Two percent of the women had a family history of cervical cancer and both patients died of the disease due to lack of facilities for treatment. Conclusions: Cervical cancer is a preventable disease but women of the sub-region are under-screened. Postnatal Pap smear is a necessary tool in its early diagnosis and treatment.

Cite this paper

Ago, B. U. , Etokidem, A. and Ebughe, G. (2016). Prevalence of Abnormal Cervical Cytology among Postnatal Clinic Attendees at the University of Calabar Teaching Hospital, Nigeria. Open Access Library Journal, 3, e2992. doi: http://dx.doi.org/10.4236/oalib.1102992.

References

[1]  Berek, J.S. and Hacker, N.F. (2000) Epidemiology and Biostatistics of Cervical Cancer. Practical Gynaecologic Oncology, 3rd Edition, Lippincott Williams and Wilkins, 7, 258.
[2]  Ago, B.U., et al. (2013) Cancer of the Uterine Cervix at the University of Calabar Teaching Hospital, Calabar, Nigeria. Cancer Research Journal, 1, 37-40.
[3]  Cohn de Herzog, T.J. (2001) New Innovations in Cervical Cancer Screening. Clinical Obstetrics and Gynecology, 44, 538-549.
[4]  Adewole, I.F. (2003) Epidemiology, Clinical Features and Management of Cervical Cancer. In: Okonofua, F. and Odunsi, K., Eds., Contemporary Obstetrics and Gynaecology for Developing Countries, Women’s Health and Action Research Center, Benin, 289-315.
[5]  Omigbodun, A.O. (2009) Epidemiology of Cervical Cancer. Colposcopy Training Workshop, Calabar.
[6]  Omigbodun, A.O. (2010) Guidelines for Cervical Cancer Screening. How to Take a Good Pap Smear. Update Course WACS Abuja.
[7]  Hasanzadeh, M. and Behtash, N. (2005) Cervical Cancer Screening. Cancer Therapy, 3, 231- 236.
[8]  Parkin, D.M., Nguyen-Dinh, X. and Day, N.E. (1985) The Impact of Screening on the Incidence of Cervical Cancer in England and Wales. British Journal of Obstetrics and Gynaecology, 92, 150-157.
[9]  Cecelia, H. Boardman. Cervical Cancer. Medscape Medical.
http://www.medscape.com/article/253513
[10]  Disaia, P.J. and Creasman, W.T. (2002) Preinvasive Disease of the Cervix. In: Disaia, P.J., Creasman, W.T., Eds., Clin Gynaecol Oncology, 6th Edition, St Louis Mosby Year Book, 1, 1-35.
[11]  Cole, P. and Morrison, A. (1980) Basic Issues in Population Screening for Cancer. Journal of the National Cancer Institute, 64, 1263-1272.
[12]  Apgar, B.S., Spitzer, M., et al. (2002) Colposcopy: Principles and Practice. An Integrated Textbook and Atlas. Saunders Company, Philadelphia, 52-56.
[13]  Garcia, A.A. Cervicalcancer.
http://emedicine.medscape.com/article/1253513
[14]  Rock, J.A. and Jones III, H.W. (2003) Cervical Cancer Precursors and Their Management. TeLindes Operative Gynaecology, 9th Edition, Lippincort Williams & Wilkins, 45, 1351- 1373.
[15]  Monk, B.J. Cervical Cancer Screening. HPV Resource.org
[16]  Siebers, A.G., et al. (2009) Pap Tests and Liquid-Based Cytology in Detecting Precancerous Lesions. JAMA, 302, 1757-1764.
http://dx.doi.org/10.1001/jama.2009.1569
[17]  Apgar, B.S., Zoschnick, L. and Wright, T.C. (2003) The 2001 Bethesda System Terminology. American Family Physician, 68, 1992-1999
[18]  Jain, A.G., Higgins, R.V. and Boyle, M.J. (1997) Management of Low-Grade Squamous Intraepithelial Lesions during Pregnancy. American Journal of Obstetrics & Gynecology, 177, 298-302. http://dx.doi.org/10.1016/S0002-9378(97)70190-X
[19]  Vlahos, G., Rodolakis, A., Diakomalis, E., et al. (2002) Conservative Management of Cervical Intraepithelial Neoplasia (CIN2-3) in Pregnant Women. Gynecologic and Obstetric Investigation, 54, 78-81. http://dx.doi.org/10.1159/000067715
[20]  Paraskevaidis, E., Koliopoulos, G., Kalantaridou, S., et al. (2002) Management and Evolution of Cervical Intraepithelial Neoplasia during Pregnancy and Postpartum. European Journal of Obstetrics and Gynecology and Reproductive Biology, 104, 67-69.
http://dx.doi.org/10.1016/S0301-2115(02)00058-1
[21]  Postpartum Care (2006) The Royal Women’s Clinical Practice Guideline. The Royal Women’s Hospital 2006. www.thewomens.org.au
[22]  Berek, J. and Hacker, N.F. (2000) Berek Practical Gynaecologic Oncology. Lippincott Williams and Wilkins Publishers, Philadelphia.
[23]  Kwame-Aryee, R. (2005) Carcinoma of the Cervix. In: Kwawukume, E.Y. and Emuveyan, E.E., Eds., Comprehensive Gynaecology in the Tropics, Graphic Packaging, Ghana, 412- 428.
[24]  Hacker, N.F., Berek, J.S., Lagasse, J.D., Charles, E.H., Savage, E.W. and Moore, J.G. (1982) Carcinoma of the Cervix Associated with Pregnancy. Obstetrics and Gynaecology, 59, 735- 746.
[25]  Jeronimo, J., Morales, O., Horna, J., et al. (2005) Visual Inspection with Acetic Acid for Cervical Cancer Screening Outside of Low Resource Settings. Revista Panamericana de Salud Pública, 17, 1-5. http://dx.doi.org/10.1590/s1020-49892005000100001
[26]  Olatunbosun, O.A., Ayangade, S.O. and Okwerekwu, G.A. (1985) Cytologic Screening for Cervical Neoplasia in Pregnancy. Tropical Journal of Obstetrics and Gynaecology, 5, 63-66.
[27]  EL-Gbobasky, A. and Herrington, S. (2005) Cervical Cancer: Epidemiology and Molecular Characteristics. In: Studd, J., Ed., Progress in Obstetrics and Gynaecology, Elsevier Science Ltd., Amsterdam, Vol. 16, 323-341.
[28]  Buckley, S.L., Tritz, D.M., et al. (1996) Lymph Node Metastases and Prognosis in Patients with Stage IA2 Cervical Cancer. Gynecologic Oncology, 63, 4-9.
http://dx.doi.org/10.1006/gyno.1996.0268
[29]  Azodi, M. and Ray, W. (2003) Premalignant Lesions of the Lower Genital Tract. In: Okonofua, F. and Odunsi, K., Eds., Contemporary Obstetrics and Gynaecology for Developing Countries, Women’s Health and Action Research Centre, Benin, 253-288.
[30]  Vaccination against Cervical Cancer. Scientific Advisory Committee Opinion Paper 9. RCOG Guidelines.
https://www.rcog.org.uk/en/guidelines-research-services/guidelines/sip9/
[31]  Brooks, M. (2013) One HPV Shot Maybe Enough to Protect against Cervical Cancer. Med- scape Medical News Online.
http://www.medscape.com/viewarticle/813780

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413